It is clear that more people, especially parents, are craving new, innovative solutions to address mental health concerns.. Not only do we know this from growing concerns nationally, but also from our “Dear Mom” spot being ranked in the top 5 most-viewed wellness videos in December, according to AcuityAds Inc.’s True Reach Insights Platform.
AdAge recognized our testing services as a “truly revolutionary solution for parents” and Genomind as a standout brand. Reports like these fuel our company’s push for genetics-based precision mental health treatment in the coming months and beyond.
To see the full breakdown of most-viewed brand-driven video ad campaigns, check out Ad Age’s article here.
Our “Dear Mom” spot seeks to capture the parent-child treatment journey, supported by our Genomind pharmacogenetic test. Watch the “Dear Mom” spot here:
What This Means For Your Family
The Genomind Pharmacogenetic Test, which is available by prescription, looks at 24 genes related to mental health treatment. It provides guidance across 10+ mental health conditions and 130+ medications to help clinicians determine:
- Which medications may be more or less likely to be effective
- Which medications may have side effects
- How you metabolize medications for personalized dosing guidance
Wondering if it can help you or your child’s mental health treatment? We can register your child’s healthcare provider or connect you to a registered Genomind provider in your area. Learn more about Genomind’s tests and services here.